Related Experiment Video
Updated: Jan 7, 2026

07:49
Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
3.7K
Causal Relationship Between Butyrate and Dyspepsia: Evidence From Two-Sample Mendelian Randomization Analysis of CSF
Yichen Cai1, Yujie Jiang1, Heran Zhou2
1Department of Pathology Sir Run Run Shaw Hospital Affiliated With Zhejiang University School of Medicine Hangzhou China.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|December 30, 2025
Summary
This study found that higher levels of cerebrospinal fluid (CSF) butyrate are genetically linked to a lower risk of dyspepsia. This suggests a neuroprotective role for butyrate in the gut-brain axis.
Area of Science:
- Neuroscience
- Gastroenterology
- Metabolomics
Background:
- Dyspepsia is a common gastrointestinal disorder with complex causes, potentially involving the gut-brain axis.
- The role of central nervous system metabolites in cerebrospinal fluid (CSF) for dyspepsia is not well understood.
Purpose of the Study:
- To explore the potential causal link between CSF metabolites and dyspepsia.
- Utilize a two-sample Mendelian randomization (MR) approach to investigate this relationship.
Main Methods:
- Conducted a two-sample MR analysis using genome-wide association study (GWAS) data.
- Analyzed CSF metabolite data from 532 individuals and dyspepsia data from UK Biobank (7586 cases, 353,608 controls).
- Employed inverse-variance weighted (IVW) method and sensitivity analyses to ensure result robustness.
Main Results:
- Elevated CSF butyrate demonstrated a significant inverse causal association with dyspepsia (IVW OR=0.997, p<0.001).
- Sensitivity analyses confirmed no significant heterogeneity or pleiotropy.
- Enrichment analysis indicated involvement of genes related to serine-type peptidase and protein catabolism.
Conclusions:
- This study provides novel genetic evidence connecting higher CSF butyrate levels to a reduced risk of dyspepsia.
- Suggests a potential neuroprotective function of butyrate within the gut-brain axis.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
879
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
879
Drugs for Treatment of Constipation-Predominant IBS
664
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
664

